Literature DB >> 2175549

Na(+)-K(+)-ATPase in adipocyte differentiation in culture.

J J Russo1, M A Manuli, F Ismail-Beigi, K J Sweadner, I S Edelman.   

Abstract

Differentiation of 3T3-L1 cells from a fibroblast to an adipocyte phenotype results in an approximately 50% decline in Na(+)-K(+)-ATPase activity and ouabain-sensitive 86Rb uptake. Kinetic analysis revealed a K 1/2 for Na+ of approximately 14 mM, a Km for ATP of approximately 0.4 mM, and maximal activation by sodium dodecyl sulfate at a 0.05 (wt/wt) detergent/protein ratio in both mature fibroblasts and adipocytes. Both fibroblasts and adipocytes exhibited Na(+)-K(+)-ATPase activity with an inhibition constant (Ki) for ouabain of approximately 10(-4) M. In addition, adipocytes exhibited a second component representing 30% of total activity with a Ki of approximately 5 x 10(-7) M. The emergence of biphasic ouabain inhibition kinetics in adipocytes raised the possibility of a change in alpha-subunit isoform composition with cytodifferentiation. This inference was evaluated by isoform-specific mRNA analysis (Northern blots) and by alpha-isoform-specific immunoassays (Western blots). Northern blots revealed a modest decrease in mRNA alpha 1, a striking increase in mRNA alpha 2, and a significant loss of mRNA beta content with differentiation of fibroblasts to adipocytes. By immunoassay, fibroblasts exhibited the alpha 1-isoform. Adipocytes exhibited an admixture of alpha 1- and alpha 2-isoforms, with alpha 2 being the more abundant isoform. There was no one-to-one correspondence either between the mRNA isoform and alpha-subunit abundances or between alpha-subunit abundances and enzymatic activity, suggesting that regulation occurs at multiple levels in this system. Findings indicate, however, that a shift in alpha-isoform composition accompanied by a change in ouabain inhibition kinetics occurs with cytodifferentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175549     DOI: 10.1152/ajpcell.1990.259.6.C968

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Alterations of Na+/K+-ATPase function in caveolin-1 knockout cardiac fibroblasts.

Authors:  Luis E M Quintas; Sandrine V Pierre; Lijun Liu; Yan Bai; Xiaochen Liu; Zi-Jian Xie
Journal:  J Mol Cell Cardiol       Date:  2010-05-06       Impact factor: 5.000

Review 2.  Regulation of the Na+/K+-ATPase by insulin: why and how?

Authors:  G Sweeney; A Klip
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

3.  Activity and expression of Na(+)-K(+)-ATPase in human placental cytotrophoblast cells in culture.

Authors:  L H Clarson; J D Glazier; S L Greenwood; C J Jones; M K Sides; C P Sibley
Journal:  J Physiol       Date:  1996-12-15       Impact factor: 5.182

Review 4.  Control of adipocyte differentiation.

Authors:  C M Smas; H S Sul
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

5.  Na,K-ATPase expression in C2C12 cells during myogenesis: minimal contribution of alpha 2 isoform to Na,K transport.

Authors:  S C Higham; J Melikian; N J Karin; F Ismail-Beigi; T A Pressley
Journal:  J Membr Biol       Date:  1993-01       Impact factor: 1.843

6.  Quantitation of Na+/K(+)-ATPase and glucose transporter isoforms in rat adipocyte plasma membrane by immunogold labeling.

Authors:  M Voldstedlund; J Tranum-Jensen; J Vinten
Journal:  J Membr Biol       Date:  1993-10       Impact factor: 1.843

7.  Na,K-ATPase in diabetic rat small intestine. Changes at protein and mRNA levels and role of glucagon.

Authors:  K Barada; C Okolo; M Field; N Cortas
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Insulin stimulates transepithelial sodium transport by activation of a protein phosphatase that increases Na-K ATPase activity in endometrial epithelial cells.

Authors:  C Deachapunya; M Palmer-Densmore; S M O'Grady
Journal:  J Gen Physiol       Date:  1999-10       Impact factor: 4.086

9.  The α2 Na+/K+-ATPase isoform mediates LPS-induced neuroinflammation.

Authors:  J A Leite; T J Isaksen; A Heuck; C Scavone; K Lykke-Hartmann
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.